Companies Dominating the Actinomycosis Market
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Novartis International AG
- Sanofi S.A.
- AstraZeneca plc
- Johnson & Johnson
- Roche Holding AG
- Eli Lilly and Company
- AbbVie Inc.
Browse Key Market Insights with Data Illustration:
In the News
- Merck acquired Acceleron Pharma Inc., a clinical-stage biopharmaceutical company developing innovative therapies for serious and life-threatening diseases, for USD 11.5 billion. The acquisition expanded Merck's portfolio of cardiovascular and oncology products and pipeline.
- Merck acquired ArQule, Inc., a clinical-stage biopharmaceutical company focused on kinase inhibitor discovery and development for the treatment of patients with cancer and other diseases, for USD 2.7 billion. The acquisition strengthened Merck's oncology pipeline and added new kinase inhibitor targets.
